AQR Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,892
| Closed | -$79K | – | 2325 |
|
|
2021
Q4 | $79K | Sell |
16,892
-12,038
| -42% | -$56.3K | ﹤0.01% | 2163 |
|
|
2021
Q3 | $221K | Sell |
28,930
-44,011
| -60% | -$336K | ﹤0.01% | 2127 |
|
|
2021
Q2 | $707K | Sell |
72,941
-65,343
| -47% | -$633K | ﹤0.01% | 1734 |
|
|
2021
Q1 | $1.14M | Buy |
138,284
+17,373
| +14% | +$144K | ﹤0.01% | 1493 |
|
|
2020
Q4 | $825K | Sell |
120,911
-9,208
| -7% | -$62.8K | ﹤0.01% | 1587 |
|
|
2020
Q3 | $1.45M | Buy |
130,119
+92,530
| +246% | +$1.03M | ﹤0.01% | 1243 |
|
|
2020
Q2 | $236K | Buy |
37,589
+8,897
| +31% | +$55.9K | ﹤0.01% | 1951 |
|
|
2020
Q1 | $53K | Buy |
+28,692
| New | +$53K | ﹤0.01% | 1999 |
|
|
2019
Q2 | – | Sell |
-10,873
| Closed | -$52K | – | 2218 |
|
|
2019
Q1 | $52K | Sell |
10,873
-147,623
| -93% | -$706K | ﹤0.01% | 2147 |
|
|
2018
Q4 | $380K | Sell |
158,496
-106,162
| -40% | -$255K | ﹤0.01% | 1878 |
|
|
2018
Q3 | $1.16M | Buy |
264,658
+101,538
| +62% | +$447K | ﹤0.01% | 1648 |
|
|
2018
Q2 | $1.17M | Buy |
+163,120
| New | +$1.17M | ﹤0.01% | 1646 |
|
|
2016
Q1 | – | Sell |
-124,448
| Closed | -$1.08M | – | 2306 |
|
|
2015
Q4 | $1.08M | Buy |
124,448
+2,617
| +2% | +$22.8K | ﹤0.01% | 1530 |
|
|
2015
Q3 | $1.02M | Buy |
+121,831
| New | +$1.02M | ﹤0.01% | 1413 |
|
|
2015
Q1 | – | Sell |
-10,700
| Closed | -$108K | – | 2358 |
|
|
2014
Q4 | $108K | Sell |
10,700
-5,100
| -32% | -$51.5K | ﹤0.01% | 2433 |
|
|
2014
Q3 | $71K | Sell |
15,800
-800
| -5% | -$3.6K | ﹤0.01% | 2472 |
|
|
2014
Q2 | $112K | Buy |
+16,600
| New | +$112K | ﹤0.01% | 2449 |
|